MedElevator
Войти в исследования American journal of dentistry · 2020
Bisphosphonate-related osteonecrosis of the jaw: Current clinical significance and treatment strategy review.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kim Jaewon, Lee Du-Hyeong, Dziak Rosemary, Ciancio Sebastian
Аннотация
PURPOSE: This review paper is intended to provide updated information about the significance of bisphosphonate-related osteonecrosis of the jaw (BRONJ) related to dental departments and also to provide treatment information. However, it does not review anti-resorptive related osteonecrosis of the jaw (ARONJ).
METHODS: PubMED was searched for published articles on BRONJ that have particular relevance to clinical aspects in orthodontics, endodontics, periodontics, prosthodontics, oral and maxillofacial surgery, implants and treatment planning. In vitro and animal studies were excluded.
RESULTS: Bisphosphonate therapy has a significant level of importance within all dental departments, and the treatments for BRONJ are diverse without any documented superiority of one over another.
CLINICAL SIGNIFICANCE: Each dental specialty must be aware of the risk of BRONJ in their patients, especially elderly ones with history of bone-related therapy or tumor. No definite consensus is made for some departments due to lack of evidence and rare cases.
METHODS: PubMED was searched for published articles on BRONJ that have particular relevance to clinical aspects in orthodontics, endodontics, periodontics, prosthodontics, oral and maxillofacial surgery, implants and treatment planning. In vitro and animal studies were excluded.
RESULTS: Bisphosphonate therapy has a significant level of importance within all dental departments, and the treatments for BRONJ are diverse without any documented superiority of one over another.
CLINICAL SIGNIFICANCE: Each dental specialty must be aware of the risk of BRONJ in their patients, especially elderly ones with history of bone-related therapy or tumor. No definite consensus is made for some departments due to lack of evidence and rare cases.